Intravenous milrinone is no better than standard therapy for people admitted with acute exacerbation of chronic heart failure

M. Cuffe, R. Califf, K. Adams, R. Benza, R. Bourge, W. Colucci, B. Massie, C. O'Connor, I. Pina, R. Quigg, M. Silver, Mihai Gheorghiade*, Marcus G. Hennersdorf

*Corresponding author for this work

Research output: Contribution to journalShort surveypeer-review

Fingerprint Dive into the research topics of 'Intravenous milrinone is no better than standard therapy for people admitted with acute exacerbation of chronic heart failure'. Together they form a unique fingerprint.